<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02778490</url>
  </required_header>
  <id_info>
    <org_study_id>R01DK107629</org_study_id>
    <secondary_id>R01DK107629</secondary_id>
    <nct_id>NCT02778490</nct_id>
  </id_info>
  <brief_title>Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton</brief_title>
  <official_title>Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Francisco Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>San Francisco Veterans Affairs Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this pre-post observational study, the investigators will enroll and follow a cohort of
      about 50 adults undergoing sleeve gastrectomy surgery for weight loss. Pre-operatively and at
      6 and 12 months post-operatively, the investigators will use state-of-the-art metabolic and
      imaging techniques to evaluate calcium metabolism and skeletal health. Specific outcomes
      include intestinal calcium absorption capacity, bone mineral density (BMD) assessed by
      dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT), and bone
      structure assessed by QCT and high-resolution peripheral QCT (HR-pQCT).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2016</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in intestinal fractional calcium absorption</measure>
    <time_frame>6 months</time_frame>
    <description>The investigators will determine whether there is a change in intestinal calcium absorption, assessed using the dual stable isotopes Ca-43 and Ca-44 in the setting of robust vitamin D status, following sleeve gastrectomy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage change in spinal volumetric bone mineral density</measure>
    <time_frame>12 months</time_frame>
    <description>The investigators will define the effects of sleeve gastrectomy on spinal volumetric bone mineral density, assessed by quantitative computed tomography (QCT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change in volumetric bone mineral density at the distal tibia</measure>
    <time_frame>12 months</time_frame>
    <description>The investigators will define the effects of sleeve gastrectomy on total volumetric bone mineral density at the distal tibia, assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change in cortical porosity at the distal tibia</measure>
    <time_frame>12 months</time_frame>
    <description>The investigators will define the effects of sleeve gastrectomy on cortical porosity at the distal tibia, assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage change in spinal volumetric bone mineral density by QCT</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage change in volumetric bone mineral density at the distal tibia by HR-pQCT</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage change in cortical porosity at the distal tibia by HR-pQCT</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage changes in cortical and trabecular volumetric bone mineral density and microstructural parameters at the radius and tibia by HR-pQCT</measure>
    <time_frame>6 months and 12 months</time_frame>
  </other_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Calcium Metabolism Disorders</condition>
  <condition>Morbid Obesity</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Obese men and women undergoing sleeve gastrectomy surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women and men 25 to 70 years old scheduled to undergo sleeve gastrectomy

        Please note that the investigators are unable to provide sleeve gastrectomy; rather,
        potential participants must already be planning the procedure with their surgeons.

        Exclusion Criteria:

          -  Perimenopausal women, defined as last menses &gt;3 months but &lt; 5 years ago

          -  Known intestinal malabsorption (e.g., celiac disease, short gut syndrome, prior
             intestinal surgery)

          -  Prior bariatric surgery

          -  Use of medications known to impact bone and mineral metabolism, including use of a
             bisphosphonate or teriparatide in the last year or for &gt;12 months ever; current
             calcitonin; prednisone &gt;5 mg daily or the equivalent glucocorticoid for &gt;10 days in
             the last 3 months; a current thiazolidinedione (TZD); an aromatase inhibitor; androgen
             deprivation therapy; an antiepileptic agent known to alter hepatic vitamin D
             clearance; or thyroid hormone replacement with current thyroid stimulating hormone &lt;
             0.1 milli-international units per liter

          -  Disease known to affect bone (e.g., primary hyperparathyroidism, Pagets disease,
             clinically significant liver disease)

          -  Illicit drug use or alcohol use &gt;3 drinks/day

          -  Serum calcium &gt;10.2 mg/dL or calculated creatinine clearance &lt; 30 mL/min

          -  Weight &gt;350 pounds (the maximum weight limit of the QCT scanner) at the time of the
             pre-operative QCT scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Schafer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Francisco VA Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Schafer, MD</last_name>
    <phone>415-221-4810</phone>
    <phone_ext>24895</phone_ext>
    <email>anne.schafer@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heather Freasier, RD</last_name>
    <phone>415-221-4810</phone>
    <phone_ext>25518</phone_ext>
    <email>heather.freasier@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole King</last_name>
      <phone>415-221-4810</phone>
      <phone_ext>10580</phone_ext>
      <email>nicole.king@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anne Schafer, MD</last_name>
      <phone>415-221-4810</phone>
      <phone_ext>24895</phone_ext>
      <email>anne.schafer@ucsf.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2016</study_first_submitted>
  <study_first_submitted_qc>May 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2016</study_first_posted>
  <last_update_submitted>February 3, 2017</last_update_submitted>
  <last_update_submitted_qc>February 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Francisco Veterans Affairs Medical Center</investigator_affiliation>
    <investigator_full_name>Anne Schafer</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine and of Epidemiology and Biostatistics; Staff Physician</investigator_title>
  </responsible_party>
  <keyword>sleeve gastrectomy, bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Calcium Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

